文献

J-GLOBAL ID：201602237216996695   整理番号：16A1175861

線維芽細胞増殖因子受容体-1蛋白質発現はエストロゲン受容体-陽性/ヒト上皮細胞増殖因子受容体-2-陰性原発性乳癌における予後と関連する

Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer

著者 (12件)： Tomiguchi Mai (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Yamamoto Yutaka (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Yamamoto-Ibusuki Mutsuko (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Yamamoto-Ibusuki Mutsuko (Department of Molecular-Targeting Therapy for Breast Cancer, Kumamoto University Hospital, Kumamoto, Japan) ,  Goto-Yamaguchi Lisa (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Fujiki Yoshitaka (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Fujiwara Saori (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Sueta Aiko (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Hayashi Mitsuhiro (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Takeshita Takashi (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Inao Touko (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan) ,  Iwase Hirotaka (Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan)
資料名： Cancer Science (Web)  (Cancer Science (Web))
巻： 107  号： 4  ページ： 491-498  発行年： 2016年 
JST資料番号： U0505A  ISSN： 1349-7006  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 近年,新規標的療法の開発に関する研究は,高度で,より個別化さ...

シソーラス用語： ヒト ,...
準シソーラス用語： ER陽性乳癌 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1175861&from=J-GLOBAL&jstjournalNo=U0505A") }}

著者キーワード (5件)： Biomarker ,  breast cancer ,  ER-positive/HER2-negative ,  fibroblast growth factor receptor-1 ,  protein expression

分類 (1件)： 腫ようの化学・生化学・病理学  (GE02030N)

引用文献 (41件)：

• Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-82.
• Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-92.
• Romond EH, Perez EA, Bryant J et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005; 353: 1673-84.
• Valachis A, Mauri D, Polyzos NP, Chlouverakis G, Mavroudis D, Georgoulias V. Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis. Breast 2011; 20: 485-90.
• Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 2009; 14: 320-68.

タイトルに関連する用語 (8件)： 線維芽細胞増殖因子 ,  受容体 ,  蛋白質発現 ,  エストロゲン受容体 ,  ヒト ,  上皮細胞増殖因子 ,  原発性乳癌 ,  予後